Demographic data
| Parameter | Entire cohort (n=366) | ASCVD cohort, age ≥40 years (n=158) |
| Age (years) | 42.5±13.1 | 49.2±5.1 |
| Sex | ||
| Female | 355 (97) | 154 (97.5) |
| Male | 11 (3) | 4 (2.5) |
| Ethnicity | ||
| Caucasian | 193 (53) | 83 (53) |
| African-American | 57 (16) | 26 (16) |
| Hispanic | 65 (18) | 25 (16) |
| Asian | 37 (10) | 17 (11) |
| Mixed/other | 14 (4) | 7 (4) |
| Hypertension | 127 (35) | 58 (37) |
| Diabetes mellitus | 19 (5) | 12 (8) |
| Current smoker | 30 (8) | 11 (7) |
| Body mass index (kg/m2) | 26.3±6.5 | 27.0±6.6 |
| Disease duration (years) | 12.0±8.9 | 14.4+9.2 |
| Total cholesterol (mg/dL) | 183.9±44.5 | 191±42.5 |
| LDL (mg/dL) | 105.4±36.2 | 108.1±35.8 |
| HDL (mg/dL) | 57.3±16.9 | 59.5±17.8 |
| Baseline SLEDAI | 3.8±4.0 | 1.6±2.0 |
| Baseline SLICC damage | 1.4±1.8 | 3.5±3.1 |
| Any anticardiolipin antibody | 132 (36) | 57 (36) |
| Mean baseline daily prednisone dose (mg) | 4.7±8.4 | 3.3±5.5 |
| Lifetime prednisone dose | ||
| Prednisone <10 g | 170 (46) | 74 (47) |
| Prednisone 10–20 g | 77 (21) | 31 (20) |
| Prednisone >20 g | 119 (33) | 53 (33) |
Data as mean±SD for continuous variables and number (%) for categorical variables.
ASCVD, Atherosclerotic Cardiovascular Disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLICC, Systemic Lupus International Collaborating Clinics.